Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

CROSSBONE Decisive early crosstalk in bone repair: vessel, nerve and stem cell interactions in healthy and Neurofibromatosis type 1 conditions

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 June 2025 to 31 May 2027
Status
Running
EU funding
€226k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101206577

What the project is doing

In the project's own words, from its summary on CORDIS.

Bone fractures are common traumatic injuries and a significant global health challenge. Successful healing depends on skeletal stem progenitor cells (SSPCs) producing cartilage and bone via a complex process. New vessel and nerve formations in the bone microenvironment are also crucial to determine the healing outcome. When disrupted, bone healing is impaired and fibrosis emerges, impacting patients’ life. In current research on bone repair disorders, there is a lack of understanding of initial triggers influencing cell differentiation and healing outcomes.

In Neurofibromatosis type 1 (NF1), the host laboratory identified an early SSPC shift from a chondrogenic fate to a fibrotic fate promoting fibrosis instead of bone formation. Analysing the factors causing this cell fate shift is essential to understand altered mechanisms in pathological conditions. CROSSBONE will address these needs by unveiling the SSPC niche initial regulatory mechanisms influencing bone healing and fibrosis.

It will analyse healthy fracture healing, detailing angiogenesis, reinnervation and SSPC interactions. Then I will investigate NF1 pathological mechanisms, focusing on this crosstalk and how it can disrupt healing. The project will use complementary in vitro and in vivo experiments, single-cell transcriptomics, and advanced tools to dissect spatial-temporal crosstalk after fractures. These interdisciplinary methodologies will provide a comprehensive understanding of bone healing in healthy and pathological conditions.

CROSSBONE will enhance my professional development, boosting independence and competitiveness for my future career. The findings will potentially impact the management of diseases where fibrosis influences bone healing, benefiting scientists, clinicians and patients in related fields. Integrating various disciplines and techniques, CROSSBONE aims to contribute pioneering insights into bone healing and fibrosis, supporting new therapeutic strategies.

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI